Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3687_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
40 Мб
Скачать
x Contributing Authors
https://t.me/med1917
Arnost Fronek, 9500 Gilman Dr., UCSD, La Jolla, CA,
USA
Steven S. Gale, Jobst Vascular Center, The Toledo Hospi-
tal, Toledo, OH, USA
María Antonia García-Olmedo Vascular Malformation
Area, Granada, Spain
Peter Gloviczki, Department of Vascular Surgery, Mayo
Clinic, Rochester, MN, USA
Mitchel P. Goldman, 7630 Fay Ave., Dermatology/
Cosmetic Laser Associates of La Jolla, Inc., La Jolla, CA, USA
Linda M. Graham, Cleveland Clinic Foundation, Depart-
ment of Vascular Surgery, Cleveland, OH, USA
Jean-Jérôme Guex, 32 Bd. Dubouchage, Phlebology Clinic,
Nice, France
John A. Heit, 200 First Street SW, Mayo Clinic, Hematol-
ogy Research, Rochester, MN, USA
Russell D. Hull, Foothills Hospital, University of Calgary,
Calgary, Alberta, Canada
Colleen M. Johnson, Division of Vascular Surgery, Depart-
ment of Surgery, Southern Illinois University School of Medicine, Springfi eld, IL, USA
Lowell Kabnick, 95 Madison Ave., Vein Institute of New
Jersey, Morristown, NJ, USA
Manju Kalra, Department of Vascular Surgery, Mayo
Clinic, Rochester, MN, USA
Robert M. Kaplan, 9500 Gilman Dr., UCSD, La Jolla, CA,
USA
Robert L. Kistner, 848 S. Beretania St. #307, Kistner Vein
Clinic, Honolulu, HI, USA
Brajesh K. Lal, 185 S. Orange Ave., UMDNJ–New Jersey
Medical School, Newark, NJ, USA
Rober D. Langer, 9500 Gilman Dr., UCSD, La Jolla, CA,
USA
Timothy K. Liem, Vascular Surgery, OP-11, Oregon Health
& Science University, Portland, OR
Peter H. Lin, Division of Vascular Surgery, Baylor College
of Medicine, Houston, TX, USA
Christopher Longo, Department of Vascular Surgery,
University of Michigan, Ann Arbor, MI, USA
Alan B. Lumsden, Division of Vascular Surgery, Baylor
College of Medicine, Houston, TX, USA
Fedor Lurie, 848 S. Beretania St. #307, Kistner Vein Clinic,
Honolulu, HI, USA
William Marston, Division of Vascular Surgery, Univer-
sity of North Carolina, Chapel Hill, NC
Elna Masuda, 888 S. King Street, Straub Clinic & Hospital,
Honolulu, HI, USA
Robert B. McLafferty, Division of Vascular Surgery,
Department of Surgery, Southern Illinois University School of Medicine, Springfi eld, IL, USA
Lisa Mekenas, Vascular Lab, Sharp Memorial Hospital,
Department of Radiology
Nick Morrison, 9755 North 90th Street, Vein & Laser
Center of Arizona, Scottsdale, AZ, USA
Geza Mozes, Department of Vascular Surgery, Mayo Clinic,
Rochester, MN, USA
Kenneth Myers, Level 5, Suite 1, Epworth Hospital
Vascular Unit, Richmond, VIC, Australia
Peter Neglén, 1020 River Oaks Dr., River Oaks Hospital,
Flowood, MS, USA
Francisco J. Osse, Rua Prof. Artur Ramos 96—cj. 41,
Venaclinic, Sao Paulo, Brazil
Frank T. Padberg, Jr., 185 S. Orange Ave., UMDNJ–New
Jersey Medical School, Newark, NJ, USA
Peter J. Pappas, 185 S. Orange Ave., UMDNJ–New Jersey
Medical School, Newark, NJ, USA
Hugo Partsch, Baumeistergasse 85, Professor of Derma-
tology, Vienna, Austria
Luigi Pascarella, 9850 Genesee Ave., The Vein Institute of
La Jolla, La Jolla, CA, USA
Eric K. Peden, Division of Vascular Surgery, Baylor
College of Medicine, Houston, TX, USA
Michel Perrin, 26 Chemlin de Decines, Clinique du Grande
Large Chassieu, France
Graham F. Pineo, 601 South Tower—Foothills Hospital,
Calgary, AB, Canada
Thomas M. Proebstle, Department of Dermatology, Uni-
versity of Heidelberg, Heidelberg, Germany
Alessandra Puggioni, Department of Vascular Surgery,
Mayo Clinic, Rochester, MN, USA
Joseph D. Raffetto, 1400 VFW Parkway, Surgery 112 Vas-
cular, VA Boston Healthcare System, Boston, MA, USA
Jeffrey K. Raines, 1501 South Miami Avenue, Miami Vein
Center, Miami, FL, USA
Seshadri Raju, 1020 River Oaks Dr., University of Missis-
sippi Medical Center, Flowood, MS, USA
Contributing Authors xi
https://t.me/med1917
Pritham P. Reddy, Division of Vascular Surgery, Depart-
ment of Surgery, Southern Illinois University School of Medicine, Springfi eld, IL, USA
G.D. Richardson, 1 MacIntosh Place, Rural Clnical School,
UNSW, Wagga Wagga, NSW, Australia
Robert B. Rutherford, 14337 Dorsal St., The University of
Colorado Medical Center/School, Corpus Christi, TX, USA
Neil Sadick, Weill Cornell Medical College of Cornell Uni-
versity, New York, NY, USA
Richard J. Sanders, 4545 East Ninth Ave. #420, Denver,
CO, USA
Geert W. Schmid-Schönbein, Department of Bioengineer-
ing, UCSD, La Jolla, CA, USA
Jocelyn A. Segall, Vascular Surgery, OP-11, Oregon Health
& Science University, Portland, OR
Mobeen A. Sheikh, Intervention Cardiology, Beth Deacon-
ess Medical Center, Boston, MA, USA
Philip Coleridge Smith, Thomas Valley Nuffi eld Hospital,
UCL Medical School, Wexham, UK
Lian Sorhaindo, Weill Cornell Medical College of Cornell
University, New York, NY
Paul Thibault, 41 Belford St., Central Vein & Cosmetic
Medical Centre, Broadmeadow, NSW, Australia
Patricia E. Thorpe, Department of Surgery, 200 Hawkins
Dr., University of Iowa Health Care, Iowa City, IA, USA
Thomas W. Wakefi eld, Department of Vascular Surgery,
University of Michigan, Ann Arbor, MI, USA
Theodore E. Warkentin, 237 Barton St. E, Hamilton
Regional Laboratory Medicine Program, Hamilton, Ontario, Canada
Margaret A. Weiss, 54 Scott Adam Rd., Johns Hopkins
School of Medicine, Baltimore, MD, USA
Robert A. Weiss, 54 Scott Adam Rd., Johns Hopkins School
of Medicine, Baltimore, MD, USA
Wei Zhou, Michael E. DeBakey Department of Sur-
gery, Baylor College of Medicine, Houston, TX, USA
Robert W. Zickler, 185 S. Orange Ave., UMDNJ–New
Jersey Medical School, Newark, NJ, USA
Steven E. Zimmet, 1801 North Lamar Blvd., Zimmet Vein
and Dermatology Clinic, Austin, TX, USA
This page intentionally left blank
https://t.me/med1917
Preface
https://t.me/med1917
Over the last decade, the art and science of surgery have changed dramatically. At this time, we in surgery are moving from open surgery to minimally invasive interventions. We have moved in some instances from operative procedures to catheter-based or endoscopic manipulations. Where data are available, we have moved from experience-driven dogma, through retrospective analysis of experience, to evidence­based medicine from prospective randomized trials. Almost all these changes can and should be viewed as good omens for our patients and for our ability and security in practicing surgery.
Some areas of surgery have been more resistant to change and have proven to be diffi cult to change. Such is the story of venous disorders. Up until quite recently, it seemed that the only solution that we could provide in evaluating venous disorders of the lower extremities was the dogma handed
down by our teachers. Now, there has been extensive scien­tifi c activity working on solutions to these stubborn prob­lems. The current volume, edited and shepherded by the eminently qualifi ed Dr. John Bergan, both catalogues the signifi cant advances in this arena and offers practitioners an up-to-date guide for treating patients. It is a most welcome effort, a superb product, and it places a scientifi c stake in the ground for the modern diagnosis and treatment of venous disorders. You will enjoy this volume, and you will refer to it frequently when treating the unfortunate individuals dis­abled by venous diseases.
Mark A. Talamini, M.D.
Professor and Chairman, Department of Surgery
University of California, San Diego
San Diego, California
USA
xiii
This page intentionally left blank
https://t.me/med1917
Prologue
https://t.me/med1917
Although it generally is acknowledged that venous disorders have an enormous socio-economic impact, diagnosis and treatment of such conditions have suffered from a lack of interest and support, especially in academic centers. All specialities have considered phlebology as a kind of unim­portant appendix to their main discipline. So this subspe­cialty has gained the reputation of a Cinderella in clinical medicine.
As a matter of fact, venous disorders are much more complex than, for instance, peripheral arterial occlusive dis­eases. At the beginning of this new millennium there are encouraging signs that the period of stagnation has ended.
The Vein Book gives impressive testimony documenting the rapid ascent of the subject of venous disorders into the world of science. The transition from dogma of the nine­teenth and twentieth century to evidence-based medicine and medicine-based evidence exemplifi es this. Future devel­opments can already be seen, and the way ahead looks very promising.
Fascinating new insights in the fi elds of basic science will certainly stimulate more clinical research. The new tools of noninvasive diagnostic instrumentation, such as the duplex Doppler, have opened our eyes to an improved anatomic and functional understanding of venous pathology. Nowadays this has become the basis for rational therapeutic decisions and for assessing the outcome after treatment.
New therapeutic options for treating varicose veins have been developed, which are less invasive and are at least as
effective as traditional surgical methods. Based on the growing experience with such procedures and on the results of comparative studies, the indications for surgery of vari­cose veins have changed and will certainly change in the near future.
Abolishing superfi cial refl ux and also advanced recon­structive surgical procedures on the deep veins may soon yield excellent results, especially in severe forms of chronic venous insuffi ciency. These conditions, especially venous ulcerations, have been considered until now to be chronic, incurable lesions.
Venous disorders frequently start with acute thrombosis. This is but one feature of a complex thromboembolic disease process that provides appealing links with other fi elds of medicine. An example is the fascinating area of coagulation disorders. A major part of this volume, The Vein Book, is written by some of the most internationally recognized experts in thrombosis research who provide genuine insights into this important subject.
The future of phlebology has already arrived, and The
Vein Book is destined to be a part of it.
Hugo Partsch, M.D.
Emeritus Head of the Dermatological Department
of the Wilhelminen Hospital, Professor at the Medical University and Honorary President of the IUP.
Vienna, November 2005
xv
This page intentionally left blank
https://t.me/med1917
Introduction
https://t.me/med1917
Venous disorders are important. They range in severity from trivial telangiectasias to death-dealing pulmonary emboliza­tion. Their impact on disability is enormous. Their cost to the economic system in Western countries is almost incal­culable. This volume intends to bring under a single hard­cover the major facets that have changed the face of diagnosis and treatment of venous disorders during the last quarter century.
Much of the activity in diagnosis and treatment of venous disorders actually has been in investigations toward causa­tion. These are well represented in this volume, where the molecular basis of venous insuffi ciency is discussed as well as in the inappropriate activity of leukocytes and how this impacts on venous function. This is discussed further in the chapters on physiologic testing of venous disorders. All of this, of course, is based on the anatomical fi ndings and the newly uncovered pathologic anatomy revealed by ultra­sound testing.
Classifi cation of venous dysfunction has undergone some revisions and has helped in making treatment of venous insuffi ciency more of a science. The fundamental basis for all treatment in venous disorders is compression therapy, and this is thoroughly discussed in this volume by a preemi­nent authority in this fi eld.
After 1970, the vascular laboratory became dominant in the study of patients with arterial diseases. After 1980, use of the Doppler and its marriage to pulsed Doppler systems made venous diagnosis more accurate. Since 1985, duplex scanning has emerged as the main direct test for diseases of the veins. The ultrasound applications are seen throughout this volume. These are mentioned many times in those chapters that deal with primary venous insuffi ciency.
In treating venous insuffi ciency, compression is funda­mental and this is well discussed, as is sclerotherapy, which is described in a number of chapters encompassing the scle-
rosants themselves, their applications, and the all important complications of sclerotherapy.
As treatment of varicose veins has changed from traumatic surgery to minimal invasion, the new modalities command attention. These include modifi cations of surgery, radiofrequency closure of the saphenous vein, use of the laser in obliteration of the saphenous vein, and the use of foam as a substitute for all three modalities. No book of this magnitude would be complete without a description of the surgical stripping of the saphenous vein, even though many phlebologists believe that to be obsolete. Part of the reasons for the downturn in interest in surgery is the phenomenon of neovascularization, which appears to be the consequence of a clean groin dissection, and that is exceedingly well described in a chapter on that subject.
Venous thromboembolic disease is an exceedingly impor­tant venous subject although it is quite separate in its think­ing from the general subject of venous insuffi ciency. A complete coverage of this subject extends from diagnosis through various forms of treatment and must contain a thor­ough discussion of prevention as well as treatment.
Finally, the post-thrombotic state of chronic venous insuffi ciency occupies much time and effort because it is essentially incurable. Aspects of its care run the full gamut from simple compression through surgery, venous recon­struction, and foam sclerotherapy to the futuristic subject of synthetic and artifi cial valves. There is much to be done in improving the care of this condition.
All these subjects and more are the content of this volume. The authors of each chapter and section join me in the hope that you will enjoy application of the knowledge as much as we have enjoyed bringing it to you.
John Bergan, M.D.
La Jolla, CA, USA
November 2005
xvii
This page intentionally left blank
https://t.me/med1917
CHAPTER
https://t.me/med1917
1
Historical Introduction
ALBERTO CAGGIATI and CLAUDIO ALLEGRA
Since the fi fth century bc, the heart has been regarded as the center of the vascular system (Empedocles of Agrigentum; 500–430 bc). In the great Epic of India, “Mahabharata,” it was stated that “all veins proceed from the heart, upwards, downwards and sideways and convey the essences of food to all parts of the body.” The Chinese Wang Shu So reported in his Mei ching, that “the heart regulates all the blood in the body . . . The blood current fl ows continuously in a circle and never stops . . .” Herasistratus (310–250 bc) was so close to the discovery of the circulation to guess the exis­tence of capillaries: “. . . the blood passes from the veins into arteries thorough ‘anastomoses,’ small inter-communicating vessels . . .”
These correct theories were darkened by Hippocratic dogma for centuries. Hippocrates of Cos, the “father of the Medicine” (460–377 bc) affi rmed in “De Nutritione” that the liver is the “root” of all veins and that the veins alone contain blood destined for the body’s nourishment. Arteries would contain an elastic ethereal fl uid, the “spirit of life.” This wrong convincement, based upon the Pythagorean doc­trine of the four humors (blood, phlegm, yellow bile, and black bile), remained the basis for medical practice for more than 2000 years!
As irrational as this theory seems to us today, more than three centuries (1316–1661) passed until it was abolished. Many authors confuted Hippocratic theories, allowing, and sometimes anticipating, Harvey’s discovery. In 1316, Mondino de Luzzi furnished a rudimental but exact descrip­tion of the circulatory system that was omitted by all subse­quent authors: “. . . Postea vero versus pulmonem est aliud
orifi cium venae arterialis, quae portat sanguinem ad pul­monem a corde; quia cum pulmo deserviat cordi secundum modum dictum, ut ei recompenset, cor ei transmittit san-
guinem per hanc venam, quae vocatur vena arterialis; est vena, quia portat sanguinem, et arterialis, quia habet duas tunicas; et habet duas tunicas, primo quia vadit ad membrum quod existit in continuo motu, et secundo quia portat san­guinem valde subtilem et cholericum . . .” The same occurred
to the Spanish Ludovicus Vassaeus and Miguel Servetus. The anatomy of the cardiovascular system was so well depicted by Vassaeus (De Anatomen Corporis Humani tabulae quator, 1544) that Marie Jean Pierre Florens affi rmed that he “. . . described the blood circulation a century before William Harvey . . .” In 1546, the anti-Arabist theologician and physician Servetus exactly described the pulmonary circulation: “. . . the blood enters the lungs by the way of the pulmonary artery in greater quantities than necessary for their nutrition, mixes with the pneuma and returns by way the pulmonary veins . . .” Servetus’ discovery did not diffuse between contemporary physicians, probably because it was reported in a theological book. Servetus’ theories were so innovative that he was accused of heresy by Calvinists and burned. Andrea Cesalpino, Professor of Medicine at Rome, fi rst identifi ed the function of the valves (. . . certain mem­branes placed at the openings of the vessels prevent the blood from returning . . .) and the centripetal direction of the fl ow in the veins (1571). He also supposed the existence of “vasa in capillamenta resoluta” (capillaries) and affi rmed that in the lung, the blood “. . . is distributed into fi ne branches and comes in contact with the air . . .” (1583). Finally, he coined the term “circulation.” According to important historians like Florens, Richet, and Castiglioni, Cesalpino’s groundwork determined the Harvey’s revolution.
In 1628, William Harvey explained in his De Motu Cordis
the theory of the blood circulation (see Figure 1.1). However, the discovery of the circulation cannot be considered
The Vein Book
1
All rights of reproduction in any form reserved.
Copyright © 2006, Elsevier Inc.